WallStreetZenWallStreetZen

NASDAQ: COLL
Collegium Pharmaceutical Inc Stock Ownership - Who owns Collegium Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Collegium Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas B. SmithEVP and Chief Medical Officer2025-08-2917,478$38.42
$671.57kSell
Scott DreyerEVP Chief Commercial Officer2025-08-1816,389$21.34
$349.74kBuy
Scott DreyerEVP Chief Commercial Officer2025-08-1816,389$38.21
$626.17kSell
Gino SantiniDirector2025-08-1515,000$13.45
$201.75kBuy
Gino SantiniDirector2025-08-155,405$37.19
$201.02kSell
Scott DreyerEVP Chief Commercial Officer2025-08-134,861$38.03
$184.88kSell
Rubric Capital Management LP10% Owner2025-08-1325,000$37.85
$946.25kSell
Scott DreyerEVP Chief Commercial Officer2025-08-134,861$21.34
$103.73kBuy
John Gordon FreundDirector2025-08-0811,659$34.36
$400.64kSell
John Gordon FreundDirector2025-06-0915,000$13.45
$201.75kBuy

1 of 4

COLL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COLL insiders and whales buy or sell their stock.

COLL Shareholders

What type of owners hold Collegium Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David Hirsch20.03%6,438,798$224.39MInsider
Rubric Capital Management LP19.57%6,290,486$219.22MInsider
Longitude Capital Partners LLC17.56%5,643,684$196.68MInsider
Blackrock Inc16.62%5,341,856$186.16MInstitution
Skyline Venture Partners V LP15.87%5,099,832$177.73MInsider
Rubric Capital Management LP9.82%3,157,743$110.05MInstitution
Eventide Asset Management LLC8.22%2,641,401$92.05MInstitution
Vanguard Group Inc6.99%2,248,211$78.35MInstitution
Yasunori Kaneko6.69%2,150,186$74.93MInsider
Frazier Healthcare VI LP5.87%1,887,332$65.77MInsider

1 of 3

COLL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COLL51.08%48.92%Net SellingNet Selling
AMPH48.28%51.72%Net BuyingNet Selling
DVAX63.58%36.42%Net SellingNet Selling
PCRX68.66%31.34%Net SellingNet Selling
CRON12.30%48.73%Net Selling
View Top Pharmaceutical Stocks

Collegium Pharmaceutical Stock Ownership FAQ

Who owns Collegium Pharmaceutical?

Collegium Pharmaceutical (NASDAQ: COLL) is owned by 111.19% institutional shareholders, 106.50% Collegium Pharmaceutical insiders, and 0.00% retail investors. David Hirsch is the largest individual Collegium Pharmaceutical shareholder, owning 6.44M shares representing 20.03% of the company. David Hirsch's Collegium Pharmaceutical shares are currently valued at $227.68M.

If you're new to stock investing, here's how to buy Collegium Pharmaceutical stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.